MTOR and rheumatoid arthritis: PI3K/AKT interacts with the mammalian target of rapamycin (mTOR) protein, inhibits fibroblastic synoviocyte (FLS) autophagy, promotes sustained synoviocyte growth, and aggravates RA (Miryala et al., 2019).